Antiviral activity of chitosan nanoparticles encapsulating silymarin (Sil–CNPs) against SARS-CoV-2 (in silico and in vitro study)

To develop a specific treatment against COVID-19, we investigated silymarin–chitosan nanoparticles (Sil–CNPs) as an antiviral agent against SARS-CoV-2 using in silico and in vitro approaches. Docking of Sil and CNPs was carried out against SARS-CoV-2 spike protein using AutoDock Vina. CNPs and Sil–C...

Descripción completa

Detalles Bibliográficos
Autores principales: Loutfy, Samah A., Abdel-Salam, Ahmed I., Moatasim, Yassmin, Gomaa, Mokhtar R., Abdel Fattah, Nasra F., Emam, Merna H., Ali, Fedaa, ElShehaby, Hasnaa A., Ragab, Eman A., Alam El-Din, Hanaa M., Mostafa, Ahmed, Ali, Mohamed A., Kasry, Amal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal Society of Chemistry 2022
Materias:
Chemistry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9132606/
https://www.ncbi.nlm.nih.gov/pubmed/35685696
http://dx.doi.org/10.1039/d2ra00905f

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9132606/
https://www.ncbi.nlm.nih.gov/pubmed/35685696
http://dx.doi.org/10.1039/d2ra00905f

Ejemplares similares